110 related articles for article (PubMed ID: 10383822)
1. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy.
Chun S; Daheshia M; Lee S; Rouse BT
Cell Immunol; 1999 Jun; 194(2):194-204. PubMed ID: 10383822
[TBL] [Abstract][Full Text] [Related]
2. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10.
Qin L; Chavin KD; Ding Y; Favaro JP; Woodward JE; Lin J; Tahara H; Robbins P; Shaked A; Ho DY
Transplantation; 1995 Mar; 59(6):809-16. PubMed ID: 7701573
[TBL] [Abstract][Full Text] [Related]
3. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10.
Chun S; Daheshia M; Lee S; Eo SK; Rouse BT
J Immunol; 1999 Sep; 163(5):2393-402. PubMed ID: 10452973
[TBL] [Abstract][Full Text] [Related]
4. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
5. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis.
Lim BK; Choe SC; Shin JO; Ho SH; Kim JM; Yu SS; Kim S; Jeon ES
Circulation; 2002 Mar; 105(11):1278-81. PubMed ID: 11901035
[TBL] [Abstract][Full Text] [Related]
6. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
7. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Todo T; Martuza RL; Dallman MJ; Rabkin SD
Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
[TBL] [Abstract][Full Text] [Related]
8. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
Broberg E; Setälä N; Röyttä M; Salmi A; Erälinna JP; He B; Roizman B; Hukkanen V
Gene Ther; 2001 May; 8(10):769-77. PubMed ID: 11420640
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
Chang Y; Prud'homme GJ
J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
12. Viral IL-10 gene transfer inhibits DTH responses to soluble antigens: evidence for involvement of genetically modified dendritic cells and macrophages.
Whalen JD; Thomson AW; Lu L; Robbins PD; Evans CH
Mol Ther; 2001 Dec; 4(6):543-50. PubMed ID: 11735338
[TBL] [Abstract][Full Text] [Related]
13. Effects of local and systemic viral interleukin-10 gene transfer on corneal allograft survival.
Gong N; Pleyer U; Volk HD; Ritter T
Gene Ther; 2007 Mar; 14(6):484-90. PubMed ID: 17093506
[TBL] [Abstract][Full Text] [Related]
14. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.
Sia KC; Wang GY; Ho IA; Khor HY; Miao L; Hui KM; Lam PY
J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404
[TBL] [Abstract][Full Text] [Related]
15. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
[TBL] [Abstract][Full Text] [Related]
17. Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.
Morini M; Albini A; Lorusso G; Moelling K; Lu B; Cilli M; Ferrini S; Noonan DM
Gene Ther; 2004 Feb; 11(3):284-91. PubMed ID: 14737088
[TBL] [Abstract][Full Text] [Related]
18. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
[TBL] [Abstract][Full Text] [Related]
19. A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis.
Khoury M; Bigey P; Louis-Plence P; Noel D; Rhinn H; Scherman D; Jorgensen C; Apparailly F
J Gene Med; 2006 Aug; 8(8):1027-36. PubMed ID: 16733831
[TBL] [Abstract][Full Text] [Related]
20. Intravenous delivery of naked plasmid DNA for in vivo cytokine expression.
Jiang J; Yamato E; Miyazaki J
Biochem Biophys Res Commun; 2001 Dec; 289(5):1088-92. PubMed ID: 11741303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
